DRIVE was set up in July 2017 to address the challenge of brand-specific Influenza Vaccine Effectiveness (IVE). After five years of intense work, including two years among the COVID-19 pandemic, we can now present the final results and lessons learnt. Discover a summary of the project’s conclusions here.
Download and share the document and help us disseminate our work!